First participant dosing expected before end of March 2025.
- Forums
- ASX - By Stock
- Ann: Nyrada Commences Phase I Clinical Trial Recruitment
NYR
nyrada inc.
Add to My Watchlist
3.03%
!
34.0¢

First participant dosing expected before end of March 2025.
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
34.0¢ |
Change
0.010(3.03%) |
Mkt cap ! $71.71M |
Open | High | Low | Value | Volume |
33.5¢ | 34.5¢ | 33.5¢ | $133.0K | 392.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 34189 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 78469 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 28000 | 0.340 |
3 | 101193 | 0.335 |
4 | 185840 | 0.330 |
4 | 113873 | 0.325 |
6 | 223489 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 78469 | 2 |
0.350 | 36795 | 5 |
0.355 | 24064 | 1 |
0.360 | 5722 | 1 |
0.365 | 42100 | 3 |
Last trade - 14.42pm 28/07/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online